Medical Xpress news
Medical Xpress / Study finds uneven burden of brain and nervous system cancers across US
A new nationwide study has revealed striking differences in how brain and nervous system cancers affect Americans depending on where they live, as well as their age, sex and socioeconomic status, according to the study published ...
Medical Xpress / Protein ubiquilin-2 found to promote Parkinson's-linked α-synuclein aggregation
Parkinson's disease (PD) is an age-related, progressive neurodegenerative disorder. The hallmark of PD pathogenesis is the Lewy bodies (LBs) that accumulate in neurons in the substantia nigra region of the brain, damaging ...
Medical Xpress / Los Angeles wildfires prompted significantly more virtual medical visits, research finds
When uncontrolled wildfires moved from the foothills above Los Angeles into the densely populated urban areas below in January 2025, evacuation ensued and a thick layer of toxic smoke spread across the region. Air quality ...
Medical Xpress / Reducing social media use for just a week can improve mental health
In a new study, published in JAMA Network Open, 295 participants report promising mental health benefits after reducing their social media usage for a week. The cohort consisted of young adults from the ages of 18 to 24—the ...
Medical Xpress / An fMRI marker of Alzheimer's-related cognitive decline
Researchers at Université Savoie Mont Blanc, Radboud University and the University of Oxford's Wellcome Center for Integrative Neuroimaging, report that attenuation of the brain's intrinsic anticorrelation between the default ...
Medical Xpress / Musicians drift less in blindfolded walk: Could musical training be utilized in cognitive rehabilitation?
A multi-institutional team of researchers led by Université de Montréal report that extensive musical training can steady the body in space, both with and without guiding sounds, during a blindfolded stepping test.
Medical Xpress / How antibody therapy clears Alzheimer's plaques: Key immune mechanism identified
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have now demonstrated the ...
Medical Xpress / Alternative sweetener sorbitol linked to liver disease
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier alternatives to food with refined sugar (glucose). But that assumption is being challenged with new ...
Medical Xpress / Metabolic roots of memory loss: Early obesity and low choline levels linked to brain inflammation risk
For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood pressure and insulin resistance strain the body's vascular and metabolic systems. Over time, that stress ...
Medical Xpress / Daily coffee drinking may slow biological aging of people with major mental illness
Drinking a maximum of 3–4 cups of coffee a day may slow the "biological" aging of people with severe mental illness, by lengthening their telomeres—indicators of cellular aging—and giving them the equivalent of 5 extra ...
Medical Xpress / Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Medical Xpress / Study reveals unexpected link between dopamine and serotonin in the brain
Researchers at Karolinska Institutet, Columbia University and the University of San Francisco, have uncovered a previously unknown mechanism by which dopamine, a key brain chemical vital for movement and motivation, can affect ...